-
1
-
-
78049485263
-
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
-
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 12:2893-2917.
-
(2010)
Int J Cancer
, vol.12
, pp. 2893-2917
-
-
Ferlay, J.1
Shin, H.R.2
Bray, F.3
Forman, D.4
Mathers, C.5
Parkin, D.M.6
-
2
-
-
70349859891
-
NCCN Clinical Practice Guidelines in Oncology: colon cancer
-
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, et al. NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Cancer Netw 2009, 7(8):778-831.
-
(2009)
J Natl Compr Cancer Netw
, vol.7
, Issue.8
, pp. 778-831
-
-
Engstrom, P.F.1
Arnoletti, J.P.2
Benson, A.B.3
Chen, Y.J.4
Choti, M.A.5
Cooper, H.S.6
Covey, A.7
Dilawari, R.A.8
Early, D.S.9
Enzinger, P.C.10
-
3
-
-
77953152570
-
Reported outcome factors for pulmonary resection in metastatic colorectal cancer
-
Pfannschmidt J, Hoffmann H, Dienemann H. Reported outcome factors for pulmonary resection in metastatic colorectal cancer. J Thorac Oncol 2010, 5(6 Suppl 2):S172-S178.
-
(2010)
J Thorac Oncol
, vol.5
, Issue.6 SUPPL. 2
-
-
Pfannschmidt, J.1
Hoffmann, H.2
Dienemann, H.3
-
4
-
-
57449096129
-
Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741
-
Sanoff HK, Sargent DJ, Campbell ME, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Goldberg RM. Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741. J Clin Oncol Off J Am Soc Clin Oncol 2008, 26(35):5721-5727.
-
(2008)
J Clin Oncol Off J Am Soc Clin Oncol
, vol.26
, Issue.35
, pp. 5721-5727
-
-
Sanoff, H.K.1
Sargent, D.J.2
Campbell, M.E.3
Morton, R.F.4
Fuchs, C.S.5
Ramanathan, R.K.6
Williamson, S.K.7
Findlay, B.P.8
Pitot, H.C.9
Goldberg, R.M.10
-
5
-
-
0026772638
-
Colorectal lung metastases: results of surgical excision
-
discussion 785-786, 10.1016/0003-4975(92)91435-C, 1570970
-
McAfee MK, Allen MS, Trastek VF, Ilstrup DM, Deschamps C, Pairolero PC. Colorectal lung metastases: results of surgical excision. Ann Thorac Surg 1992, 53(5):780-785. discussion 785-786, 10.1016/0003-4975(92)91435-C, 1570970.
-
(1992)
Ann Thorac Surg
, vol.53
, Issue.5
, pp. 780-785
-
-
McAfee, M.K.1
Allen, M.S.2
Trastek, V.F.3
Ilstrup, D.M.4
Deschamps, C.5
Pairolero, P.C.6
-
6
-
-
3042535457
-
Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma
-
10.1016/j.athoracsur.2004.02.017, 15223436
-
Inoue M, Ohta M, Iuchi K, Matsumura A, Ideguchi K, Yasumitsu T, Nakagawa K, Fukuhara K, Maeda H, Takeda S, et al. Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. Ann Thorac Surg 2004, 78(1):238-244. 10.1016/j.athoracsur.2004.02.017, 15223436.
-
(2004)
Ann Thorac Surg
, vol.78
, Issue.1
, pp. 238-244
-
-
Inoue, M.1
Ohta, M.2
Iuchi, K.3
Matsumura, A.4
Ideguchi, K.5
Yasumitsu, T.6
Nakagawa, K.7
Fukuhara, K.8
Maeda, H.9
Takeda, S.10
-
7
-
-
34547135192
-
Pulmonary resection for metastases from colorectal cancer: prognostic factors and survival
-
10.1007/s00384-006-0218-2, 17109105
-
Lee WS, Yun SH, Chun HK, Lee WY, Yun HR, Kim J, Kim K, Shim YM. Pulmonary resection for metastases from colorectal cancer: prognostic factors and survival. Int J Colorectal Dis 2007, 22(6):699-704. 10.1007/s00384-006-0218-2, 17109105.
-
(2007)
Int J Colorectal Dis
, vol.22
, Issue.6
, pp. 699-704
-
-
Lee, W.S.1
Yun, S.H.2
Chun, H.K.3
Lee, W.Y.4
Yun, H.R.5
Kim, J.6
Kim, K.7
Shim, Y.M.8
-
8
-
-
33745206277
-
Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer
-
10.1016/j.athoracsur.2006.02.027, 16798225
-
Iizasa T, Suzuki M, Yoshida S, Motohashi S, Yasufuku K, Iyoda A, Shibuya K, Hiroshima K, Nakatani Y, Fujisawa T. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer. Ann Thorac Surg 2006, 82(1):254-260. 10.1016/j.athoracsur.2006.02.027, 16798225.
-
(2006)
Ann Thorac Surg
, vol.82
, Issue.1
, pp. 254-260
-
-
Iizasa, T.1
Suzuki, M.2
Yoshida, S.3
Motohashi, S.4
Yasufuku, K.5
Iyoda, A.6
Shibuya, K.7
Hiroshima, K.8
Nakatani, Y.9
Fujisawa, T.10
-
9
-
-
60949111944
-
Lung metastases from colorectal cancer: surgical resection and prognostic factors
-
10.1016/j.ejcts.2008.10.047, 19136273
-
Rama N, Monteiro A, Bernardo JE, Eugenio L, Antunes MJ. Lung metastases from colorectal cancer: surgical resection and prognostic factors. Eur J Cardiothorac Surg 2009, 35(3):444-449. 10.1016/j.ejcts.2008.10.047, 19136273.
-
(2009)
Eur J Cardiothorac Surg
, vol.35
, Issue.3
, pp. 444-449
-
-
Rama, N.1
Monteiro, A.2
Bernardo, J.E.3
Eugenio, L.4
Antunes, M.J.5
-
10
-
-
33846550144
-
Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer
-
10.1016/j.ejcts.2006.11.004, 17150367
-
Welter S, Jacobs J, Krbek T, Poettgen C, Stamatis G. Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer. Eur J Cardiothorac Surg 2007, 31(2):167-172. 10.1016/j.ejcts.2006.11.004, 17150367.
-
(2007)
Eur J Cardiothorac Surg
, vol.31
, Issue.2
, pp. 167-172
-
-
Welter, S.1
Jacobs, J.2
Krbek, T.3
Poettgen, C.4
Stamatis, G.5
-
11
-
-
40749149728
-
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
-
10.1016/S0140-6736(08)60455-9, 2277487, 18358928
-
Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008, 371(9617):1007-1016. 10.1016/S0140-6736(08)60455-9, 2277487, 18358928.
-
(2008)
Lancet
, vol.371
, Issue.9617
, pp. 1007-1016
-
-
Nordlinger, B.1
Sorbye, H.2
Glimelius, B.3
Poston, G.J.4
Schlag, P.M.5
Rougier, P.6
Bechstein, W.O.7
Primrose, J.N.8
Walpole, E.T.9
Finch-Jones, M.10
-
12
-
-
70349690209
-
Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial
-
10.1038/sj.bjc.6605259, 2768086, 19789532
-
Okines A, Puerto OD, Cunningham D, Chau I, Van Cutsem E, Saltz L, Cassidy J. Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial. Br J Cancer 2009, 101(7):1033-1038. 10.1038/sj.bjc.6605259, 2768086, 19789532.
-
(2009)
Br J Cancer
, vol.101
, Issue.7
, pp. 1033-1038
-
-
Okines, A.1
Puerto, O.D.2
Cunningham, D.3
Chau, I.4
Van Cutsem, E.5
Saltz, L.6
Cassidy, J.7
-
13
-
-
79959947067
-
A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection
-
Wong R, Cunningham D, Barbachano Y, Saffery C, Valle J, Hickish T, Mudan S, Brown G, Khan A, Wotherspoon A, et al. A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection. Ann Oncology Off J Eur Soc Med Oncol / ESMO 2011, 22(9):2042-2048.
-
(2011)
Ann Oncology Off J Eur Soc Med Oncol / ESMO
, vol.22
, Issue.9
, pp. 2042-2048
-
-
Wong, R.1
Cunningham, D.2
Barbachano, Y.3
Saffery, C.4
Valle, J.5
Hickish, T.6
Mudan, S.7
Brown, G.8
Khan, A.9
Wotherspoon, A.10
-
14
-
-
84867840155
-
Survival with cetuximab/FOLFOX or cetuximab/FOLFIRI of patients with nonresectable colorectal liver metastases in the CELIM study
-
abstr 540
-
Folprecht G, Gruenberger T, Bechstein W, Lordick F, Lang H, Weitz J, Suedhoff T, Hartmann JT, Liersch T, Kohne C-H. Survival with cetuximab/FOLFOX or cetuximab/FOLFIRI of patients with nonresectable colorectal liver metastases in the CELIM study. J Clin Oncol 2012, 30(suppl 4):abstr 540.
-
(2012)
J Clin Oncol
, vol.30
, Issue.SUPPL. 4
-
-
Folprecht, G.1
Gruenberger, T.2
Bechstein, W.3
Lordick, F.4
Lang, H.5
Weitz, J.6
Suedhoff, T.7
Hartmann, J.T.8
Liersch, T.9
Kohne, C.-H.10
-
15
-
-
4444375263
-
Retrospective study of resection of pulmonary metastases in patients with advanced colorectal cancer: the development of a preoperative chemotherapy strategy
-
10.3816/CCC.2004.n.013, 15285817
-
Negri F, Musolino A, Cunningham D, Pastorino U, Ladas G, Norman AR. Retrospective study of resection of pulmonary metastases in patients with advanced colorectal cancer: the development of a preoperative chemotherapy strategy. Clin Colorectal Cancer 2004, 4(2):101-106. 10.3816/CCC.2004.n.013, 15285817.
-
(2004)
Clin Colorectal Cancer
, vol.4
, Issue.2
, pp. 101-106
-
-
Negri, F.1
Musolino, A.2
Cunningham, D.3
Pastorino, U.4
Ladas, G.5
Norman, A.R.6
-
16
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
-
10.1093/jnci/92.3.205, 10655437
-
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000, 92(3):205-216. 10.1093/jnci/92.3.205, 10655437.
-
(2000)
J Natl Cancer Inst
, vol.92
, Issue.3
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
Wanders, J.4
Kaplan, R.S.5
Rubinstein, L.6
Verweij, J.7
Van Glabbeke, M.8
van Oosterom, A.T.9
Christian, M.C.10
-
17
-
-
33845382806
-
Non parametric estimation from incomplete observations
-
Kaplan E, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.1
Meier, P.2
-
18
-
-
0036830515
-
Pulmonary metastasectomy for 165 patients with colorectal carcinoma: A prognostic assessment
-
10.1067/mtc.2002.125165, 12407386
-
Saito Y, Omiya H, Kohno K, Kobayashi T, Itoi K, Teramachi M, Sasaki M, Suzuki H, Takao H, Nakade M. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: A prognostic assessment. J Thorac Cardiovasc Surg 2002, 124(5):1007-1013. 10.1067/mtc.2002.125165, 12407386.
-
(2002)
J Thorac Cardiovasc Surg
, vol.124
, Issue.5
, pp. 1007-1013
-
-
Saito, Y.1
Omiya, H.2
Kohno, K.3
Kobayashi, T.4
Itoi, K.5
Teramachi, M.6
Sasaki, M.7
Suzuki, H.8
Takao, H.9
Nakade, M.10
-
19
-
-
70349439259
-
Pulmonary resection for metastases from colorectal carcinoma
-
10.1510/icvts.2009.202598, 19635733
-
Maeda R, Isowa N, Onuma H, Miura H, Harada T, Touge H, Tokuyasu H, Kawasaki Y. Pulmonary resection for metastases from colorectal carcinoma. Interact Cardiovasc Thorac Surg 2009, 9(4):640-644. 10.1510/icvts.2009.202598, 19635733.
-
(2009)
Interact Cardiovasc Thorac Surg
, vol.9
, Issue.4
, pp. 640-644
-
-
Maeda, R.1
Isowa, N.2
Onuma, H.3
Miura, H.4
Harada, T.5
Touge, H.6
Tokuyasu, H.7
Kawasaki, Y.8
-
20
-
-
1642540077
-
Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer
-
10.1002/bjs.4370, 14716804
-
Kanemitsu Y, Kato T, Hirai T, Yasui K. Preoperative probability model for predicting overall survival after resection of pulmonary metastases from colorectal cancer. Br J Surg 2004, 91(1):112-120. 10.1002/bjs.4370, 14716804.
-
(2004)
Br J Surg
, vol.91
, Issue.1
, pp. 112-120
-
-
Kanemitsu, Y.1
Kato, T.2
Hirai, T.3
Yasui, K.4
-
21
-
-
34250335967
-
Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series
-
10.1016/j.athoracsur.2007.02.093, 17588454
-
Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg 2007, 84(1):324-338. 10.1016/j.athoracsur.2007.02.093, 17588454.
-
(2007)
Ann Thorac Surg
, vol.84
, Issue.1
, pp. 324-338
-
-
Pfannschmidt, J.1
Dienemann, H.2
Hoffmann, H.3
-
22
-
-
59949091448
-
Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer
-
Bokemeyer C, Bondarenko I, Makhson A, Hartmann JT, Aparicio J, de Braud F, Donea S, Ludwig H, Schuch G, Stroh C, et al. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer. J Clin Oncol Off J Am Soc Clin Oncol 2009, 27(5):663-671.
-
(2009)
J Clin Oncol Off J Am Soc Clin Oncol
, vol.27
, Issue.5
, pp. 663-671
-
-
Bokemeyer, C.1
Bondarenko, I.2
Makhson, A.3
Hartmann, J.T.4
Aparicio, J.5
de Braud, F.6
Donea, S.7
Ludwig, H.8
Schuch, G.9
Stroh, C.10
-
23
-
-
63849088630
-
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer
-
10.1056/NEJMoa0805019, 19339720
-
Van Cutsem E, Kohne CH, Hitre E, Zaluski J, Chang Chien CR, Makhson A, D'Haens G, Pinter T, Lim R, Bodoky G, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 2009, 360(14):1408-1417. 10.1056/NEJMoa0805019, 19339720.
-
(2009)
N Engl J Med
, vol.360
, Issue.14
, pp. 1408-1417
-
-
Van Cutsem, E.1
Kohne, C.H.2
Hitre, E.3
Zaluski, J.4
Chang Chien, C.R.5
Makhson, A.6
D'Haens, G.7
Pinter, T.8
Lim, R.9
Bodoky, G.10
-
24
-
-
63449116518
-
Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases
-
10.1097/SLA.0b013e31819a0486, 19247029
-
Masi G, Loupakis F, Pollina L, Vasile E, Cupini S, Ricci S, Brunetti IM, Ferraldeschi R, Naso G, Filipponi F, et al. Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases. Ann Surg 2009, 249(3):420-425. 10.1097/SLA.0b013e31819a0486, 19247029.
-
(2009)
Ann Surg
, vol.249
, Issue.3
, pp. 420-425
-
-
Masi, G.1
Loupakis, F.2
Pollina, L.3
Vasile, E.4
Cupini, S.5
Ricci, S.6
Brunetti, I.M.7
Ferraldeschi, R.8
Naso, G.9
Filipponi, F.10
-
25
-
-
77349110719
-
Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial
-
10.1016/S1470-2045(09)70381-X, 20106720
-
Chua YJ, Barbachano Y, Cunningham D, Oates JR, Brown G, Wotherspoon A, Tait D, Massey A, Tebbutt NC, Chau I. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial. Lancet Oncol 2010, 11(3):241-248. 10.1016/S1470-2045(09)70381-X, 20106720.
-
(2010)
Lancet Oncol
, vol.11
, Issue.3
, pp. 241-248
-
-
Chua, Y.J.1
Barbachano, Y.2
Cunningham, D.3
Oates, J.R.4
Brown, G.5
Wotherspoon, A.6
Tait, D.7
Massey, A.8
Tebbutt, N.C.9
Chau, I.10
-
26
-
-
33745726677
-
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
-
10.1056/NEJMoa055531, 16822992
-
Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006, 355(1):11-20. 10.1056/NEJMoa055531, 16822992.
-
(2006)
N Engl J Med
, vol.355
, Issue.1
, pp. 11-20
-
-
Cunningham, D.1
Allum, W.H.2
Stenning, S.P.3
Thompson, J.N.4
Van de Velde, C.J.5
Nicolson, M.6
Scarffe, J.H.7
Lofts, F.J.8
Falk, S.J.9
Iveson, T.J.10
-
27
-
-
77649209505
-
Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study
-
Fernandez-Martos C, Pericay C, Aparicio J, Salud A, Safont M, Massuti B, Vera R, Escudero P, Maurel J, Marcuello E, et al. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study. J Clin Oncol Off J Am Soc Clin Oncol 2010, 28(5):859-865.
-
(2010)
J Clin Oncol Off J Am Soc Clin Oncol
, vol.28
, Issue.5
, pp. 859-865
-
-
Fernandez-Martos, C.1
Pericay, C.2
Aparicio, J.3
Salud, A.4
Safont, M.5
Massuti, B.6
Vera, R.7
Escudero, P.8
Maurel, J.9
Marcuello, E.10
-
28
-
-
62849128239
-
Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases
-
10.1016/S1470-2045(09)70064-6, 19261256
-
Chun YS, Laurent A, Maru D, Vauthey JN. Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases. Lancet Oncol 2009, 10(3):278-286. 10.1016/S1470-2045(09)70064-6, 19261256.
-
(2009)
Lancet Oncol
, vol.10
, Issue.3
, pp. 278-286
-
-
Chun, Y.S.1
Laurent, A.2
Maru, D.3
Vauthey, J.N.4
-
29
-
-
77953350910
-
The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy
-
Strimpakos AS, Cunningham D, Mikropoulos C, Petkar I, Barbachano Y, Chau I. The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy. Ann Oncol Off J Eur Soc Med Oncol / ESMO 2010, 21(5):1013-1019.
-
(2010)
Ann Oncol Off J Eur Soc Med Oncol / ESMO
, vol.21
, Issue.5
, pp. 1013-1019
-
-
Strimpakos, A.S.1
Cunningham, D.2
Mikropoulos, C.3
Petkar, I.4
Barbachano, Y.5
Chau, I.6
|